This negative feedback loop mediated by human IFNβ and activated CD4+CD45RO+ memory T–cells is likely to limit inflammation and immunopathology during the course of the immune response to viruses, and might contribute to the therapeutic effects of IFNβ in MS. The gene discussed is IFNB1; the disease is myeloid sarcoma.